SKAN Group

SKAN Group EBIT per Share

The EBIT per Share of SKAN Group (SKAN.SW) as of Nov 3, 2026 is 1.13 CHF. In the previous year, EBIT per Share was 2.10 CHF — a change of -46.14% (lower).

EBIT per Share

1.13CHF

YoY

-46.14%

Last updated:

EBIT per Share of SKAN Group is 2025 1.13 CHF. EBIT per Share of SKAN Group was 2024 2.10 CHF. It decreases by -46.14% lower compared to the previous year.

The SKAN Group EBIT per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT per Share
Date
EBIT per Share
Jan 1, 2023
1.68 CHF
Jan 1, 2024
2.10 CHF
Jan 1, 2025
1.13 CHF
Jan 1, 2026 (e)
1.99 CHF
Jan 1, 2027 (e)
2.65 CHF
Jan 1, 2028 (e)
3.38 CHF
Jan 1, 2029 (e)
4.34 CHF
Jan 1, 2030 (e)
5.57 CHF
The SKAN Group EBIT per Share history
YEAREBIT per ShareYoY
est5.57CHF+28.35%
est4.34CHF+28.43%
est3.38CHF+27.81%
est2.65CHF+32.68%
est1.99CHF+76.29%
1.13CHF-46.14%
2.10CHF+25.05%
1.68CHF+28.14%
1.31CHF+56.84%
0.84CHF+64.85%
0.51CHF-70.14%
1.70CHF+212.41%
0.54CHF-63.30%
1.48CHF-6.09%
1.58CHF-12.45%
1.80CHF+290.37%
0.46CHF+86.75%
0.25CHF-39.74%
0.41CHF—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

SKAN Group Stock analysis

What does SKAN Group do? The SKAN Group AG is a Swiss company that was founded in 1968 by Hans-Rudolf Huber. The company started as a supplier of cleanroom equipment and has since grown into a leading provider of solutions in the field of cleanroom technology and isolator technology. SKAN's business model consists of responsibly implementing demanding and innovative projects for customers in the life sciences industry. In close collaboration with the client, SKAN offers customized solutions that ensure the highest safety standards and efficiency in facilities and processes. SKAN divides its business into three divisions: cleanroom technology, isolator technology, and bio-decontamination. Cleanroom technology provides solutions for the construction of cleanroom infrastructures in research and production. Isolator technology is used to ensure safety in pharmaceutical production by shielding the contents of the isolator from the operator and the environment. Bio-decontamination is a method for inactivating biological contaminations using formalin. SKAN's products include highly customizable and flexible cleanroom and isolator solutions. In particular, SKAN's isolator solutions are world-leading and meet the highest requirements for safety and quality. Therefore, they can be found in pharmaceutical production as well as research laboratories worldwide. SKAN also develops its own systems for bio-decontamination, which are used in pharmaceutical production and healthcare. SKAN Bio-decontamination is a revolutionary method based on formalin that combats bacteria, viruses, and living organisms. These bio-decontamination systems are quick, effective, and safe. The success of SKAN is based on a high degree of innovation, excellent customer service, and consistent implementation of the highest quality and safety standards. The company is not only internationally active but also globally recognized and valued for its expertise and solutions in cleanroom and isolator technology, as well as bio-decontamination. SKAN Group is one of the most popular companies on Eulerpool.

Frequently Asked Questions about SKAN Group stock

EBIT per Share of SKAN Group is 1.13 CHF in 2025.

EBIT per Share of SKAN Group changed from 2.10 CHF to 1.13 CHF, representing a -46.14% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBIT per Share SKAN Group since 2006 – with annual values, charts, and detailed analysis.

EBIT per Share measures operating profit allocated to each outstanding share.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — SKAN Group

All Key Metrics — SKAN Group